Scarica l'app Stockscreener
0.7898
2.73%
-0.0222
Dopo l'orario di chiusura:
.78
-0.0098
-1.24%
AEON Biopharma Inc. Borsa (AEON) Ultime notizie
What analysts say about AEON Biopharma Inc. stockMassive stock growth - PrintWeekIndia
Is AEON Biopharma Inc. a good long term investmentTremendous portfolio expansion - PrintWeekIndia
Will AEON Biopharma Inc. stock benefit from AI tech trendsUnmatched profit growth - jammulinksnews.com
What drives AEON Biopharma Inc. stock priceFree Capital Efficiency Planning - PrintWeekIndia
AEON Biopharma Inc. Stock Analysis and ForecastRapid growth opportunities - jammulinksnews.com
why aeon biopharma inc. stock attracts strong analyst attentionFree Investment Community - Newser
what makes aeon biopharma inc. stock price move sharplyROI Focused Stock Calls - Newser
Why AEON Biopharma Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
What makes AEON Biopharma Inc. stock price move sharplyFree Access to Investment Community - Newser
How AEON Biopharma Inc. stock performs during market volatilitySmart Return Focused Trading - Newser
AEON Biopharma (NASDAQ:AEON) Trading Down 10.2% – Should You Sell? - Defense World
AEON Biopharma Holds Annual Stockholders Meeting - TipRanks
AEON Biopharma, Inc. (NASDAQ:AEON) Short Interest Update - Defense World
AEON Biopharma Soars 13.67% on CEO Appointment, Talent Grants - AInvest
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
AEON Biopharma Expands Team with 100K+ Stock Awards: Inside the Biotech's Latest Hiring Move - Stock Titan
Aeon Biopharma Reports Positive Q1 2025 Earnings - TipRanks
AEON Biopharma Releases New Corporate Presentation - TipRanks
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - The Manila Times
AEON Biopharma to Present Corporate Overview at Aegis Capital Corp. 2025 Virtual Conference - Nasdaq
AEON Biopharma Unveils Next-Gen Botulinum Toxin Therapies: CEO Details Multi-Indication Pipeline - Stock Titan
AEON Biopharma Advances Biosimilar Product Development and Appoints New CEO - Nasdaq
AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
New AEON CEO Targets $3.3B Botox Market with FDA-Ready Biosimilar Development Plan - Stock Titan
AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Tuesday - Defense World
0.97%
0.22%
Capitalizzazione:
|
Volume (24 ore):